Patent ID: 8524463

Claim:
A method for the in-vitro diagnosis or prognosis of acute coronary syndrome, or post-myocardial infarction, comprising determining the level of CT-pro-ET-1 in at least one blood sample from a patient, wherein said CT-pro-ET-1 refers to SEQ ID NO: 2, or SEQ ID NO: 3, or both, and determining the level of NT-proBNP (SEQ ID NO: 4) in said at least one blood sample from said patient, wherein an increased level of CT-pro-ET-1 and an increased level of NT-proBNP in said at least one sample indicates the presence in said patient of acute coronary syndrome, or an increased risk of or an unfavorable prognosis of acute coronary syndrome or post-myocardial infarction for said patient.